In a coordinated policy update aimed at strengthening pharmaceutical regulation across the country, the Pharmacists Association of Belize (PAB) and the nation’s Ministry of Health and Wellness have finalized an agreement to implement a 12-month phased transition for new mandatory prescription requirements covering most prescription medications. The framework was agreed upon during a stakeholder gathering held April 13 at Belize’s Western Regional Hospital, bringing together public health officials and pharmacy leaders to address gaps in current dispensing practices.
Under the transition terms, pharmacists will retain limited permission to continue supplying chronic disease medications — including those used to manage diabetes and hypertension — to established patients even if their existing prescriptions have expired. All such dispensing transactions, however, must be formally recorded in an official prescription register to maintain full regulatory transparency and patient care tracking.
This gradual rollout applies exclusively to medications used to treat non-communicable chronic conditions. Strict, no-exception prescription mandates already in place for antibiotics and controlled substances will remain unchanged, with regulators retaining their current tight oversight of these high-risk drug classes to curb overuse and misuse.
One notable restriction that will remain in effect through the transition period applies to oral contraceptives: the medication will only be dispensed to continuing users who already hold a prior prescription. Pharmacists are prohibited from initiating new contraceptive therapy for first-time users under the current rules. PAB has submitted a formal standardized dispensing protocol for oral contraceptives to the Ministry of Health and Wellness, which is currently undergoing official review.
In a related move, the Ministry has reopened the public list of over-the-counter (OTC) medications for a full regulatory revision. PAB has been tasked with developing evidence-based recommendations for updates to the OTC list, with all proposals required to align with established international pharmaceutical safety standards.
Both regulatory and industry stakeholders emphasize that the 12-month transition period is designed to give the general public sufficient time to adapt to the new requirements, rather than creating new access privileges for medications. To support public understanding of the changes, a joint public education campaign is already in planning stages. The campaign will include educational content focused on medication safety distributed via video, as well as targeted outreach efforts to reach rural communities that may face greater barriers to accessing new information and care.
Jada Parchue, president of the Pharmacists Association of Belize, highlighted the balanced approach of the new policy in a statement following the agreement. “The twelve-month transition protects patient continuity of care while the public is sensitised on the prescription requirements,” Parchue explained.